Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy

• Ranjit Nair,
• Gaëlle Drillet,
• Faustine Lhomme,
• Anthony Le Bras,
• Laure Michel,
• John Rossi,
• Marika Sherman,
• Allen Xue,
• Anne Kerber,
• Nutchawan Jittapiromsak,
• Linda Chi,
• Sudhakar Tummala,
• Sattva S. Neelapu,
• Roch Houot

Affiliations

Ranjit Nair

Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA;

Gaëlle Drillet

CHU Rennes, Department of Hematology, University of Rennes, Rennes, France;

Faustine Lhomme

CHU Rennes, Department of Hematology, University of Rennes, Rennes, France;

Anthony Le Bras

CHU Rennes, Department of Radiology, University of Rennes, Rennes, France;

Laure Michel

CHU Rennes, Department of Neurology, University of Rennes, Rennes, France;

John Rossi

Kite, a Gilead company, Santa Monica, California, USA;

Marika Sherman

Kite, a Gilead company, Santa Monica, California, USA;

Allen Xue

Kite, a Gilead company, Santa Monica, California, USA;

Anne Kerber

Kite, a Gilead company, Santa Monica, California, USA;

Nutchawan Jittapiromsak

Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA;

Linda Chi

Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA;

Sudhakar Tummala

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA

Sattva S. Neelapu

Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA;

Roch Houot

CHU Rennes, Department of Hematology, University of Rennes, Rennes, France;